Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
11.10
+1.33 (13.61%)
Nov 9, 2026, 12:03 PM EST - Market open
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $67.89 million as of November 9, 2026. It is the 28,549th most valuable company in the world and the 4,451st biggest in the United States. Its market cap has decreased by 87.57% in one year.
Market Cap
67.89M
Enterprise Value
50.93M
1-Year Change
-87.57%
Global Rank
Country Rank
#4,451 United States
Category
ChartMarket Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $67.89M, a decrease of -93.18%. That is a compound annual growth rate of -29.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 67.89M | -90.54% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nordicus Partners | 62.70M |
| Cingulate | 61.95M |
| Cardiff Oncology | 61.87M |
| Fortress Biotech | 61.70M |
| Spero Therapeutics | 59.98M |
| Corbus Pharmaceuticals Holdings | 59.38M |
| XBiotech | 57.62M |
| Kalaris Therapeutics | 57.61M |